U.S. healthcare brightens tame U.S. high-grade M&A lending

NEW YORK (Reuters) - CVS Health Corp’s planned US$66bn buy of Aetna Inc is poised to boost the healthcare sector’s share of US investment-grade mergers and acquisitions lending beyond its current one-third share of the US$122bn total as the sector remains a bright spot in an otherwise lackluster market.